| Literature DB >> 1441700 |
T Paul1, A Reimer, H C Kallfelz.
Abstract
Junctional ectopic tachycardia is associated with a poor prognosis when it occurs in newborns and young infants. Like other automatic tachyarrhythmias, junctional ectopic tachycardia has been shown to be very resistant to medical treatment. Successful therapy with propafenone in a newborn with congenital junctional ectopic tachycardia is presented. Due to its high effectiveness, safety, and lack of side-effects, propafenone appears to be a valuable drug in the treatment of young patients with congenital junctional ectopic tachycardia.Entities:
Mesh:
Substances:
Year: 1992 PMID: 1441700
Source DB: PubMed Journal: Z Kardiol ISSN: 0300-5860